Abramowitz Y, Jilaihawi H, Chakravarty T, Mack MJ, Makkar RR. Mitral Annulus Calcification. J Am Coll Cardiol. 2015;66(17):1934–41. doi:https://doi.org/10.1016/j.jacc.2015.08.872.

Article  PubMed  Google Scholar 

Massera D, Kizer JR, Dweck MR. Mechanisms of mitral annular calcification. Trends Cardiovasc Med. 2020;30(5):289–95. doi:https://doi.org/10.1016/j.tcm.2019.07.011.

Article  CAS  PubMed  Google Scholar 

Allison MA, Cheung P, Criqui MH, Langer RD, Wright CM. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation. 2006;113(6):861–6. doi:https://doi.org/10.1161/CIRCULATIONAHA.105.552844.

Fox E, Harkins D, Taylor H, McMullan M, Han H, Samdarshi T, et al. Epidemiology of mitral annular calcification and its predictive value for coronary events in African Americans: the Jackson Cohort of the Atherosclerotic Risk in Communities Study. Am Heart J. 2004;148(6):979–84. doi:https://doi.org/10.1016/j.ahj.2004.05.048.

Article  PubMed  Google Scholar 

O’Neal WT, Efird JT, Nazarian S, Alonso A, Michos ED, Szklo M, et al. Mitral annular calcification progression and the risk of atrial fibrillation: results from MESA. Eur Heart J Cardiovasc Imaging. 2018;19(3):279 – 84. doi:https://doi.org/10.1093/ehjci/jex093.

Fox CS, Vasan RS, Parise H, Levy D, O’Donnell CJ, D’Agostino RB, et al. Framingham Heart Study. Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation. 2003 Mar 25; 107(11):1492–6. doi:https://doi.org/10.1161/01.cir.0000058168.26163.bc.

Garg PK, Guan W, Karger AB, Steffen BT, Budoff M, Tsai MY. Lipoprotein (a) and risk for calcification of the coronary arteries, mitral valve, and thoracic aorta: The Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Comput Tomogr. 2021 Mar-Apr;15(2):154–60. doi:https://doi.org/10.1016/j.jcct.2020.06.002.

Article  PubMed  Google Scholar 

Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res. 2006 Nov 10;99(10):1044–59. doi:https://doi.org/10.1161/01.RES.0000249379.55535.21.

Chen HY, Engert JC, Thanassoulis G. Risk factors for valvular calcification. Curr Opin Endocrinol Diabetes Obes. 2019;26(2):96–102. doi:https://doi.org/10.1097/MED.0000000000000471.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grundy S, Becker D, Clark L, Cooper R, Denke M, Howard H, et al. “Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).”JAMA. 2001;285(19):2486–97. doi:https://doi.org/10.1001/jama.285.19.2486.

Kajikawa M, Higashi Y. Triglycerides and endothelial function: molecular biology to clinical perspective. Curr Opin Lipidol. 2019;30(5):364–9. doi:https://doi.org/10.1097/MOL.0000000000000630.

Article  CAS  PubMed  Google Scholar 

Tran-Dinh A, Diallo D, Delbosc S, Varela-Perez LM, Dang QB, Lapergue B, et al. HDL and endothelial protection. Br J Pharmacol. 2013;169(3):493–511. doi:https://doi.org/10.1111/bph.12174.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Afshar M, Luk K, Do R, Dufresne L, Owens DS, Harris TB, et al. CHARGE Extracoronary Calcium Working Group. Association of Triglyceride-Related Genetic Variants With Mitral Annular Calcification. J Am Coll Cardiol. 2017 20;69(24):2941–8. doi:https://doi.org/10.1016/j.jacc.2017.04.051.

Edwards MK, Blaha MJ, Loprinzi PD. Atherogenic Index of Plasma and Triglyceride/High-Density Lipoprotein Cholesterol Ratio Predict Mortality Risk Better Than Individual Cholesterol Risk Factors, Among an Older Adult Population. Mayo Clin Proc. 2017;92(4):680-1. doi:https://doi.org/10.1016/j.mayocp.2016.12.018.

Zhu X, Yu L, Zhou H, Ma Q, Zhou X, Lei T, et al. Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China. Lipids Health Dis. 2018 5;17(1):37. doi:https://doi.org/10.1186/s12944-018-0686-8.

Bhardwaj S, Bhattacharjee J, Bhatnagar MK, Tyagi S. Atherogenic index of plasma, Castelli risk index and atherogenic coefficient- new parameters in assessing cardiovascular risk. Int J Pharm Bio Sci. 2013;3:359–64.

Google Scholar 

Millán J, Pintó X, Muñoz A, Zúñiga M, Rubiés-Prat J, Pallardo LF, et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–65.

PubMed  PubMed Central  Google Scholar 

Dobiásová M, Frohlich J, Sedová M, Cheung MC, Brown BG. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res. 2011;52(3):566–71. doi:https://doi.org/10.1194/jlr.P011668.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sell S, Scully RE. Aging changes in the aortic and mitral Valves. Histologic and histochemical Studies, with observations on the pathogenesis of calcific aortic stenosis and calcification of the mitral annulus. Am J Pathol. 1965;46:345–65.

CAS  PubMed  PubMed Central  Google Scholar 

Arounlangsy P, Sawabe M, Izumiyama N, Koike M. Histopathogenesis of early stage mitral annular calcification. J Med Dent Sci. 2004;51(1):35–44. https://doi.org/10.11480/jmds.510105.

Article  PubMed  Google Scholar 

Ziyrek M, Tayyareci Y, Yurdakul S, Sahin ST, Yıldırımtürk O, Aytekin S. Association of mitral annular calcification with endothelial dysfunction, carotid intima-media thickness and serum fetuin-A: an observational study. Anadolu Kardiyol Derg. 2013 Dec;13(8):752–8. doi:https://doi.org/10.5152/akd.2013.235.

Article  CAS  PubMed  Google Scholar 

Massera D, Trivieri MG, Andrews JPM, Sartori S, Abgral R, Chapman AR, et al. Disease Activity in Mitral Annular Calcification. Circ Cardiovasc Imaging. 2019 Feb;12(2):e008513. doi:https://doi.org/10.1161/CIRCIMAGING.118.008513.

Article  PubMed  PubMed Central  Google Scholar 

Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103(11):1522–8. doi:https://doi.org/10.1161/01.cir.103.11.1522.

Article  PubMed  Google Scholar 

Manjunath CN, Rawal JR, Irani PM, Madhu K. Atherogenic dyslipidemia. Indian J Endocrinol Metab. 2013;17(6):969–76. doi:https://doi.org/10.4103/2230-8210.122600.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Padró T, Vilahur G, Badimon L. Dyslipidemias and Microcirculation. Curr Pharm Des. 2018;24(25):2921–6. doi:https://doi.org/10.2174/1381612824666180702154129.

Article  CAS  PubMed  Google Scholar 

Gradinaru D, Borsa C, Ionescu C, Prada GI. Oxidized LDL and NO synthesis Biomarkers of endothelial dysfunction and ageing. Mech Ageing Dev. 2015;151:101–13. doi:https://doi.org/10.1016/j.mad.2015.03.003.

Article  CAS  PubMed  Google Scholar 

Ye X, Kong W, Zafar MI, Chen LL. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019;18(1):48. doi:https://doi.org/10.1186/s12933-019-0851-z.

Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases. Oxid Med Cell Longev. 2017;2017:1273042. doi:https://doi.org/10.1155/2017/1273042.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014;34(5):1069–77. doi:https://doi.org/10.1161/ATVBAHA.114.303284.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawler PR, Akinkuolie AO, Chu AY, Shah SH, Kraus WE, Craig D, et al. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol. J Am Heart Assoc. 2017;6(7):e005549. doi:https://doi.org/10.1161/JAHA.117.005549.

Article  PubMed  PubMed Central  Google Scholar 

Moriyama K. The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses. Intern Med. 2020 Nov 1;59(21):2661-9. doi:https://doi.org/10.2169/internalmedicine.4954-20.

Elmariah S, Budoff MJ, Delaney JA, Hamirani Y, Eng J, Fuster V, et al. Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosis. Am Heart J. 2013;166(5):904–12. doi:https://doi.org/10.1016/j.ahj.2013.08.015.

Article  PubMed  PubMed Central  Google Scholar 

Allison MA, Pavlinac P, Wright CM. The differential associations between HDL, non-HDL and total cholesterols and atherosclerotic calcium deposits in multiple vascular beds. Atherosclerosis. 2007;194(2):87–94. doi:https://doi.org/10.1016/j.atherosclerosis.2006.10.006.

Article  CAS  Google Scholar 

Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, et al. Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;9(23):2389–97. doi:https://doi.org/10.1056/NEJMoa043876. 352 ) .

Article  Google Scholar 

Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;25(13):1343–56. doi:https://doi.org/10.1056/NEJMoa0804602. 359 ) .

Article  Google Scholar 

Smith JG, Luk K, Schulz CA, Engert JC, Do R, Hindy G, et al. Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) Extracoronary Calcium Working Group. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. JAMA. 2014;312(17):1764–71. doi:https://doi.org/10.1001/jama.2014.13959.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thanassoulis G, Massaro JM, Cury R, Manders E, Benjamin EJ, Vasan RS, et al. Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium. J Am Coll Cardiol. 2010;55(22):2491–8. doi:https://doi.org/10.1016/j.jacc.2010.03.019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fox CS, Guo CY, Larson MG, Vasan RS, Parise H, O’Donnell CJ, et al. Relations of inflammation and novel risk factors to valvular calcification. Am J Cardiol. 2006;97(10):1502–5. doi:https://doi.org/10.1016/j.amjcard.2005.11.086.

Article  PubMed  Google Scholar 

Ezeigwe A, Fashanu OE, Zhao D, Budoff MJ, Otvos JD, Thomas IC, et al. The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2019;282:91–9. doi:https://doi.org/10.1016/j.atherosclerosis.2019.01.011.

Article  CAS  PubMed  PubMed Central  Google Scholar